Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug TestingBisiayo E. Fashemi 1, Lillian van Biljon 1, Jeimmy Rodriguez 1, Olivia Graham 1, Mary Mullen 1, Dineo Khabele 1
1Washington University of Medicine in St. Louis
We present a protocol that can be used to conduct therapeutic drug testing with patient-derived ovarian cancer organoids.